Notes - Consolidated Statement Of Income

ReproCELL Incorporated - Filing #7246939

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Notes - Consolidated statement of income
Notes - Consolidated statement of income
Notes regarding write-downs of inventories
Write-downs of inventories
34,466,000 JPY
6,517,000 JPY
Major components of selling, general and administrative expenses
Research and development expenses included in general and administrative expenses and manufacturing costs for period
Research and development expenses included in general and administrative expenses and manufacturing costs for period
536,787,000 JPY
286,675,000 JPY
230,595,000 JPY
384,963,000 JPY
Notes regarding impairment losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.